From May 12-13 OIFE was represented by Alessandra Tolaccia at the iDR26 – the International Drug Repurposing Conference 2026 in Brussels. The conference was an inspiring gathering of researchers, clinicians, patient advocates, and industry leaders organized by the project REMEDi4ALL. From AI-driven discovery to patient-led innovation, the energy around faster, more accessible treatments is real. Beyond…
OIF Annual Scientific Meeting 2025 in Chicago “Translating discoveries into therapies” Written by Lidiia Zhytnik, OIFE Advisory Board Member The 25th annual OIF Investigator meeting took place 9-11 of April 2025. Traditionally held in Chicago, the OIF investigator meeting invites more than 100 top (almost exclusively) US and Canada scientists and clinicians working on improving…
On the 6th and 7th of March 2024, the international conference iDR24 took place in the Modernist Campus at Sant Pau Hospital in Barcelona (Spain), organized by REMEDi4ALL, Beacon for Rare Diseases and MeRIT. More than 50 speakers from across this broad range of disciplines gathered to deep-dive into the evolving landscape of drug repurposing.…
The Remedi4All consortium & the MOI-A Trial (Losartan) Information provided by Claudia Fuchs, EURORDIS What is Remedi4All? The EU-funded multidisciplinary consortium REMEDi4ALL (Repurposing Medicines for All) has an ambition to establish a European research and innovation eco-system that facilitates fast and cost-effective patient-centric development and implementation of repurposed medicines, meeting high unmet medical needs in…
EURORDIS launched Winter School with the aim of deepening patient representatives’ understanding of how pre-clinical research translates into real benefits for rare disease patients. The training equips participants with knowledge and skills so they are empowered to effectively participate in discussions with the researchers, policy makers and companies responsible for research or research infrastructures. The 2nd edition…
